Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells-Reference-Cited by-同舟云学术

Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells

Published:2012-07-02 Issue:19 Volume:32 Page:2390-2402
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Cotrim C Z,Fabris V,Doria M L,Lindberg K,Gustafsson J-Å,Amado F,Lanari C,Helguero L A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2012261.pdf

Reference50 articles.

1. Liu Y, Gao H, Marstrand TT, Strom A, Valen E, Sandelin A et al. The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc Natl Acad Sci USA 2008; 105: 2604–2609.

2. Grober OM, Mutarelli M, Giurato G, Ravo M, Cicatiello L, De Filippo MR et al. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics 2011; 12: 36.

3. Ciarloni L, Mallepell S, Brisken C . Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci USA 2007; 104: 5455–5460.

4. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K et al. Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 2002; 99: 15578–15583.

5. Helguero LA, Faulds MH, Gustafsson JA, Haldosen LA . Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 2005; 24: 6605–6616.

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico analysis of Naringenin and its O-alkyl derivatives for its potential binding with Estrogen Receptor- α;Research Journal of Biotechnology;2024-07-31

2. Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer;Cancers;2024-07-24

3. The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer;Cancer Treatment Reviews;2024-07

4. Secular Increasing Trends in Female Thyroid Cancer Incidence in Taiwan;Life;2024-06-26

5. Estrogen α and β Receptor Expression in the Various Regions of Resected Glioblastoma Multiforme Tumors and in an In Vitro Model;International Journal of Molecular Sciences;2024-04-08